Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.42 |
| ▸ | CA6 | P23280 | 5/20 | 0.42 |
| ▸ | CA7 | P43166 | 5/20 | 0.42 |
| ▸ | CA9 | Q16790 | 5/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.42 |
| ▸ | CA2 | P00918 | 4/20 | 0.42 |
| ▸ | CA4 | P22748 | 4/20 | 0.42 |
| ▸ | CA5A | P35218 | 4/20 | 0.42 |
| ▸ | CA3 | P07451 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | F13A1 | P00488 | 2/20 | 0.41 |
| ▸ | THPO | P40225 | 2/20 | 0.41 |
| ▸ | CASP2 | P42575 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31516286 | 0.98 | CA12 (0.41) | CA12CA6CA7CA9CA14 | |
| SCHEMBL29101225 | 0.98 | CA12 (0.41) | CA12CA6CA7CA9CA14 | |
| SCHEMBL22228082 | 0.98 | CA12 (0.41) | CA12CA6CA7CA9CA14 | |
| SCHEMBL12190483 | 0.98 | CA12 (0.41) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1072257 | 0.98 | CA12 (0.41) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1585717 | 0.96 | CA12 (0.41) | CA12CA6CA7CA9CA14 | |
| SCHEMBL2833000 | 0.94 | CA12 (0.50) | CA12CA6CA7CA9CA14 | |
| SCHEMBL31142102 | 0.94 | CA12 (0.48) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18766 | 0.94 | CA12 (0.44) | CA12CA6CA7CA9CA14 | |
| SCHEMBL28779129 | 0.92 | CA12 (0.48) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240065963-A1 | MULTICOMPONENT COMPOSITION (Michael Addition) | WELLA INT OPERATIONS SWITZERLAND SARL (CH) | 2024-02-29 | — | — | US | claimed |
| US-11766394-B2 | Multicomponent composition (Michael addition) | WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) | 2023-09-26 | — | — | US | claimed |
| CN-113265160-B | Preparation method of 12-hydroxystearic acid structure modified graphene oxide material | 复旦大学 | 2021-10-26 | — | — | CN | claimed |
| CN-113265160-A | Preparation method of 12-hydroxystearic acid structure modified graphene oxide material | 复旦大学 | 2021-08-17 | — | — | CN | claimed |
| US-4317123-A | Thermal recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1982-02-23 | — | — | US | claimed |
| US-12603206-B2 | Composite component and method for producing same | NICHIA CORPORATION (JP) | 2026-04-14 | — | — | US | disclosed |
| EP-4691523-A1 | MEDICAL INSTRUMENT, TREATMENT SOLUTION, AND METHOD FOR MANUFACTURING MEDICAL INSTRUMENT | JMS Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20250285790-A1 | METHODS OF PRODUCING BONDED MAGNET AND COMPOUND FOR BONDED MAGNETS | NICHIA CORPORATION (JP) | 2025-09-11 | — | — | US | disclosed |
| US-12381023-B2 | Methods of producing bonded magnet and compound for bonded magnets | NICHIA CORPORATION (JP) | 2025-08-05 | — | — | US | disclosed |
| US-20250149240-A1 | COMPOUND FOR BONDED MAGNET, BONDED MAGNET, METHOD OF PRODUCING SAME, AND RESIN COMPOSITION FOR BONDED MAGNETS | NICHIA CORPORATION (JP) | 2025-05-08 | — | — | US | disclosed |
| US-12230438-B2 | Compound for bonded magnet, bonded magnet, method of producing same, and resin composition for bonded magnets | NICHIA CORPORATION (JP) | 2025-02-18 | — | — | US | disclosed |
| WO-2024204412-A1 | MEDICAL INSTRUMENT, TREATMENT SOLUTION, AND METHOD FOR MANUFACTURING MEDICAL INSTRUMENT | 株式会社ジェイ・エム・エス | 2024-10-03 | — | — | WO | disclosed |
| US-6077908-A | VINYL POLYMER HAVING A PRIMARY ACID AMIDE GROUP AND AN ACID IMIDE GROUP. EXCELLENT IN HEAT STABILITY IN MOLDING AND WEATHERABILITY AND SUITED FOR USE AS A MOLDING MATERIAL FOR ELECTRIC AND ELECTRONIC PARTS AND AUTOMOTIVE PARTS. | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 2000-06-20 | — | — | US | disclosed |
| US-4804579-A | Thermoinsulating moldings containing a porous, inorganic thermoinsulating material and having an organopolysiloxane coating thereon | WACKER-CHEMIE GMBH (DE) | 1989-02-14 | — | — | US | disclosed |
| EP-0284085-A1 | Heat-insulating shaped article on the basis of porous inorganic heat-insulating material with a coating of organopolysiloxane | Wacker-Chemie GmbH (DE) | 1988-09-28 | — | — | EP | disclosed |
| EP-0164609-B1 | PROCESS FOR STRENGTHENING THE BONDING OF ELASTOMERS AND COATINGS OBTAINED BY THIS PROCESS | Wacker-Chemie GmbH (DE) | 1987-04-08 | — | — | EP | disclosed |
| US-4637958-A | Method for improving the adhesion of elastomers to a coated substrate | WACKER-CHEMIE GMBH (DE) | 1987-01-20 | — | — | US | disclosed |
| US-4600657-A | Protective coatings for asphaltic concrete surfaces and methods for forming the same | WACKER-CHEMIE GMBH (DE) | 1986-07-15 | — | — | US | disclosed |
| EP-0164609-A1 | Process for strengthening the bonding of elastomers and coatings obtained by this process | Wacker-Chemie GmbH (DE) | 1985-12-18 | — | — | EP | disclosed |
| EP-0153500-A2 | Process for the production of protective layers on coatings made of asphaltic concrete and protected coatings | Wacker-Chemie GmbH (DE) | 1985-09-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12603206-B2 | Composite component and method for producing same | EED, RER1, TESK2 | CA12 2085/4885CA6 1835/4885CA7 1777/4885 |
| US-11766394-B2 | Multicomponent composition (Michael addition) | KRT18, EXOSC10, CUTA | CA12 2159/4885CA6 2732/4885CA7 3479/4885 |
| US-20240065963-A1 | MULTICOMPONENT COMPOSITION (Michael Addition) | KRT18, EXOSC10, CUTA | CA12 2159/4885CA6 2732/4885CA7 3479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.